#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15760	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2302	825.5	0	.	n	.	0	.1416G	INS	1416	1416	G	1681	1681	G	1014	G	772	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15760	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2302	825.5	0	.	n	.	0	C1525T	SNP	1525	1525	C	1790	1790	T	933	T,C	686,246	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15760	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2302	825.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1448	1448	C	1005	C,G,T,A	1001,2,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15760	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2302	825.5	0	HET	.	.	.	T1412TGGGGGG,TGGGGG	.	1412	1412	T	1676	1676	T	1010	TGGGGGG,TGGGGG	719,231	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27672	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3996	861.8	0	.	n	.	0	T695C	SNP	695	695	T	1259	1259	C	1034	C	1034	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27672	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3996	861.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	2202	2202	G	1015	G,A,C	1013,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27672	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3996	861.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2535	2535	C	995	C,G	994,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27672	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3996	861.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2609	2609	A	944	A,T	943,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27672	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3996	861.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3161	3161	C	1004	C,G	1001,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2350	folP	855	855	100.0	folP.l15.c17.ctg.1	1993	146.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1264	1266	AGC	257;257;255	A;G;C	257;257;255	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5372	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3904	171.1	1	SNP	p	S91F	1	.	.	271	273	TTC	821	823	TTC	213;213;215	T;T,G,C;C	213;211,1,1;215	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5372	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3904	171.1	1	SNP	p	G95N	0	.	.	283	285	GGC	833	835	GGC	220;218;216	G;G,A;C	220;217,1;216	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5372	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3904	171.1	1	SNP	p	D95G	1	.	.	283	285	GGC	833	835	GGC	220;218;216	G;G,A;C	220;217,1;216	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	2070	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1639	156.9	0	.	p	.	0	F184L	NONSYN	550	552	TTC	1102	1104	TTG	214;214;214	T,A;T;G,A	213,1;214;213,1	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	2070	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1639	156.9	1	SNP	p	G45D	0	.	.	133	135	GGC	685	687	GGC	268;267;266	G;G;C,T	268;267;265,1	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1128	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1466	95.7	0	.	n	.	0	A197.	DEL	197	197	A	898	898	A	213	A,C	212,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5182	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3349	192.7	1	SNP	p	D86N	0	.	.	256	258	GAC	773	775	GAC	200;197;196	G;A;C,T	200;197;195,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5182	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3349	192.7	1	SNP	p	R87W	0	.	.	259	261	CGT	776	778	CGT	195;199;197	C,A;G;T,G,C,A	194,1;199;193,2,1,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5182	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3349	192.7	1	SNP	p	S87R	1	.	.	259	261	CGT	776	778	CGT	195;199;197	C,A;G;T,G,C,A	194,1;199;193,2,1,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5182	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3349	192.7	1	SNP	p	R87I	0	.	.	259	261	CGT	776	778	CGT	195;199;197	C,A;G;T,G,C,A	194,1;199;193,2,1,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5182	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3349	192.7	1	SNP	p	S88P	0	.	.	262	264	TCC	779	781	TCC	197;197;199	T;C,A;C	197;196,1;199	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4372	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2984	182.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1710	1712	GGC	243;238;234	G,T;G;C	240,3;238;234	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4278	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2739	194.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1373	1375	GCA	255;256;260	G,T;C;A,G	254,1;256;259,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4278	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2739	194.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1376	1378	ATC	259;262;259	A,G,T;T;C	256,2,1;262;259	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4278	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2739	194.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1388	1390	GTG	261;263;265	G;T,A;G,C,A	261;262,1;263,1,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4278	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2739	194.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1388	1390	GTG	261;263;265	G;T,A;G,C,A	261;262,1;263,1,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4278	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2739	194.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1892	1894	ACC	266;266;266	A;C;C	265;265;265	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4278	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2739	194.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1946	1948	GCG	241;241;239	G;C,G;G,C	241;240,1;238,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4278	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2739	194.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1946	1948	GCG	241;241;239	G;C,G;G,C	241;240,1;238,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4278	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2739	194.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2069	2071	AGC	223;221;222	A;G;C	222;221;222	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4278	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2739	194.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2078	2080	GGC	226;227;228	G;G;C	226;227;228	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4278	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2739	194.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2096	2098	CCG	234;236;240	C,T;C,T;G	232,2;235,1;240	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5724	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3638	195.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1868	1870	CCG	219;220;224	C;C;G	219;220;224	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2638	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2223	147.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	823	823	C	199	C	199	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	100	94.0	porB1a.l15.c17.ctg.2	180	58.3	0	.	p	.	0	M18T	NONSYN	52	54	ATG	131	133	ACG	72;67;67	A;C;G	72;67;67	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	100	94.0	porB1a.l15.c17.ctg.2	180	58.3	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	173	175	CAA	19;18;16	C;A;A	19;18;16	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c17.ctg.3	301	29.4	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	23;24;26	T;T;A	23;24;26	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c17.ctg.3	301	29.4	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	57;57;57	C;A;T	57;57;57	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c17.ctg.3	301	29.4	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	57;57;57	A;G;T	57;57;57	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c17.ctg.3	301	29.4	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	57;57;57	T;A;C	57;57;57	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c17.ctg.3	301	29.4	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	4;4;4	G;C,A;A	4;3,1;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c17.ctg.3	301	29.4	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	5;5;5	G;C;A	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c17.ctg.3	301	29.4	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	5;6;6	G,T;A;C	4,1;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c17.ctg.3	301	29.4	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	6;6;6	A;T;C	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c17.ctg.3	301	29.4	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	6;6;6	T;C;G,A	6;6;5,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c17.ctg.3	301	29.4	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	6;6;6	G;C;C	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c17.ctg.3	301	29.4	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	6;6;6	A;G;C	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c17.ctg.3	301	29.4	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	6;6;6	G,C;C;C	5,1;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c17.ctg.3	301	29.4	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	6;6;6	G,T;T;T	5,1;6;6	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3056	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1777	210.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	453	455	GAA	280;276;276	G;A;A,T	280;276;275,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3056	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1777	210.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	741	743	GAT	281;283;284	G,T;A;T	280,1;283;284	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3056	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1777	210.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	864	866	TCA	283;283;280	T;C,A,T;A,G	283;281,1,1;279,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3056	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1777	210.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	993	995	GTC	216;210;208	G;T;C	216;210;207	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3056	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1777	210.2	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1005	1007	TCT	211;213;215	T,C;C;T	210,1;213;215	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3056	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1777	210.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1323	1325	GCA	249;250;252	G,A,T;C,T,A;A	246,2,1;247,2,1;252	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3056	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1777	210.2	1	SNP	p	G120K	1	.	.	358	360	AAG	699	701	AAG	280;283;285	A,G;A,G,C;G,T	279,1;281,1,1;284,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3056	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1777	210.2	1	SNP	p	A121D	1	.	.	361	363	GAC	702	704	GAC	290;290;291	G;A,C,G;C	290;287,2,1;291	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3056	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1777	210.2	1	SNP	p	D121N	0	.	.	361	363	GAC	702	704	GAC	290;290;291	G;A,C,G;C	290;287,2,1;291	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10460	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5324	244.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1556	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1587	122.2	1	SNP	p	V57M	1	.	.	169	171	ATG	825	827	ATG	273;271;268	A;T,G;G	273;270,1;268	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
